Article Information
- April 12, 2025.
Article Versions
- You are currently viewing Version 1 of this article (April 12, 2025 - 14:40).
- View Version 2, the most recent version of this article.
Author Information
- Maryam Hadji*,#,1,
- Elaheh Moradi*,1,
- Jussi Tohka*,1,
- Alzheimer’s Disease Neuroimaging Initiative, and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing**
- 1A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio 70150, Finland
- ↵#Corresponding author; email: maryam.hadji{at}uef.fi
↵* Equal contribution.
↵** Data used in the preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (www.adni.loni.usc.edu) and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing (AIBL) funded by the Commonwealth Scientific and Industrial Research Organisation (CSIRO), which was made available at the ADNI database. The investigators within ADNI and AIBL contributed to the design and implementation of ADNI/AIBL and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. AIBL researchers are listed at www.aibl.csiro.au.
